SG Americas Securities’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-60,507
Closed -$132K 3408
2013
Q3
$132K Buy
60,507
+28,887
+91% +$61.6K ﹤0.01% 2482
2013
Q2
$65K Buy
+31,620
New +$56.6K ﹤0.01% 2158

SG Americas Securities's TGX Position: Q4 2013 in Review

SG Americas Securities sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 60,507 shares — an estimated $132K sold.

SG Americas Securities first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $132K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • SG Americas Securities reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • SG Americas Securities sold 60,507 THERAGENICS CORP shares in Q4 2013, an estimated $132K.
  • SG Americas Securities first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • SG Americas Securities's THERAGENICS CORP position peaked at $132K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on SG Americas Securities's 13F filing for Q4 2013, filed 12 Feb 2014.